Internal Medicine, Infectious Disease · New Rochelle, NY
NPI
1518926617
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
16 Guion Pl
New Rochelle, NY, 10801
Phone (914) 632-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
907 services
Medicare patients, 2024
211
Average age 78
Drug cost, 2024
$1.3M
926 prescriptions
Company payments, 2025
$14.78
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey A Lederman was code 99232 (hospital e&m - subsequent), 480 times for 135 patients. In total Jeffrey A Lederman billed 907 services in 12 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 480 | 135 | $68.01 | $33K |
| 99233 Hospital E&M - Subsequent | Facility | 144 | 48 | $100.26 | $14K |
| 99222 Hospital E&M - Initial | Facility | 98 | 91 | $111.85 | $11K |
| 99214 Office E&M - Established | Facility | 59 | 32 | $81.28 | $4,796 |
| 99223 Hospital E&M - Initial | Facility | 53 | 45 | $147.12 | $7,797 |
| 99213 Office E&M - Established | Facility | 33 | 20 | $54.10 | $1,785 |
| 99231 Hospital E&M - Subsequent | Facility | 16 | 12 | $44.10 | $706 |
| 99204 Office E&M - New | Facility | 11 | 11 | $118.91 | $1,308 |
By year: 2022 $106K for 1,256 services; 2023 $94K for 1,063 services; 2024 $75K for 907 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey A Lederman prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 92 prescriptions and refills. In total Jeffrey A Lederman wrote 926 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 92 | 92 | 12 | $355K |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 60 | 84 | Under 11 | $128K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 50 | 64 | Under 11 | $236K |
| Isentress Raltegravir Potassium | 40 | 52 | Under 11 | $103K |
| Descovy Emtricitabine/Tenofov Alafenam | 38 | 42 | Under 11 | $93K |
| Valacyclovir Valacyclovir Hcl | 31 | 31 | Under 11 | $264 |
| Acyclovir Generic | 30 | 44 | Under 11 | $243 |
| Abacavir Abacavir Sulfate | 27 | 55 | Under 11 | $9,912 |
| Tivicay Dolutegravir Sodium | 26 | 26 | Under 11 | $59K |
| Tamsulosin Hcl Generic | 25 | 33 | Under 11 | $112 |
| Amlodipine Besylate Generic | 24 | 30 | Under 11 | $82.99 |
| Pravastatin Sodium Generic | 23 | 29 | Under 11 | $167 |
| Hydrochlorothiazide Generic | 23 | 31 | Under 11 | $25.2 |
| Ritonavir Generic | 22 | 30 | Under 11 | $2,476 |
| Metformin Hcl Generic | 22 | 30 | Under 11 | $116 |
Brand drugs: 334 claims; generic drugs: 592 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey A Lederman $14.78 ($14.78 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $14.78.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $14.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.